Salmoporc gives protection against Salmonella Typhimurium and its monophasic variants. It is administered orally to piglets and through subcutaneous injection in sows.
According to the company, Salmoporc is the only live, attenuated salmonella vaccine licensed for pigs in the UK and Ireland.
Ceva says salmonella in UK and Irish herds is the highest in the EU, with a prevalence of 19.5% and 17.5% respectively. It is particularly difficult to control in outdoor herds since the bacteria can survive in soil for a year, even longer in dried dung and has been detected in fields two years after being vacated by pigs.
Outdoor bred, or reared, pigmeat accounts for 12% of retail sales and the majority of this is processed.
Dr Rike Schmelz from Ceva said: "Salmonella is an increasing problem on pig farms and the bacteria are transmitted through breeding pyramids which eventually supply finishing pigs. Clinical cases of diarrhoea often occur after weaning and tend to be treated with antibiotics."
Rike added: "The monophasic variant of S. Typhimurium is already multi-drug resistant and vaccinating pigs can help farmers to substantially reduce their use of expensive antibiotics. In addition, with the removal of zinc oxide at therapeutic levels from the feed in mid-2022, salmonella and other enteric diseases are likely to become more apparent."
Ceva says that by immunising their pigs against S. Typhimurium, farmers will gain an economic benefit from lowered mortality and improved daily liveweight gain (DLWG) among their pigs.
In independent trials at the University of Ghent in Belgium, between three and 29 weeks, vaccinated piglets from three herds gained between 30g and 39g, significantly more per day than unvaccinated controls.
Trials in Germany have shown that, with vaccination of sows and gilts at the top of the breeding pyramid, combined with a competent hygiene programme, it is possible to eliminate salmonella from the supply chain.
Virtual Vet Derms has been set up to be able to give advice to veterinary surgeons on any aspect of skin or ear disease whether it is allergy, otitis media, cutaneous neoplasia or endocrine-based in any species, including dogs, cats, small furries, exotic pets including raptors, birds and reptiles, horses, camelids, zoo and farm animals.
Sue, herself an RCVS Recognised Specialist in Veterinary Dermatology, is supported by a team of veterinary dermatology colleagues as well as veterinary specialists in exotic medicine, internal medicine (including endocrinology) and consultants with expertise in oncology.
Sue said: "We recognise that not every veterinarian has got access to a local dermatology specialist and that not all clients can or want to travel to a referral centre. The aim of the service is to formalise the advice that dermatology clinicians give to veterinary surgeons to allow them to get detailed help to manage difficult or challenging dermatology cases within their own practice."
The service has been set up under the RCVS Vivet initiative, is approved by all of the major insurance companies and supported with Veterinary Defence Society Insurance cover.
Virtual Vet Derms offers support in a range of ways.
Quick questionsShort questions that veterinary surgeons can submit via the online form on the Virtual Vet Derms website that just require a brief reply. This may be a dose of a drug, a parasite you want identifying, or the interpretation of a blood sample such as an ACTH stimulation test.
Veterinary reportsVeterinary surgeons can use online request forms on the Virtual Vet Derms web site to submit a brief history of the animal and the problem and some good quality photos of the skin condition. There is also the ability to upload histopathology reports, blood samples and any other pertinent information. A detailed written report is sent back to the vet within 48 hours which will describe clinical signs, differential diagnoses, recommended diagnostic tests and treatment option where appropriate. Where possible, Virtual Vet Derms aims to pass the advice request to the nearest dermatologist but vets can ask for advice from any of its specialists.
Telemedicine consultationsFor new cases or for cases where initial advice has been sought, in the client's own primary care veterinary practice via the internet. The Virtual Vets Derms specialist can consult with the owner to provide even more specific advice and support. After each teleconsultation the Virtual Vet Derms specialist will produce a report in the same format as the veterinary report to allow the primary care veterinary surgeon to continue to manage the case more effectively.
Face to face consultationsCan also be arranged via the owner’s vet at the specialist's own practice if there is the need for more specialist investigation that may not be available in the primary care veterinary surgery. In these cases, the specialist will take on the direct care of the case and work with the owner and vet on the best course of action.
General advice Also possible if the vet wishes to direct an owner straight to Virtual Vet Derms.
For more information, visit: https://virtualvetderms.com
Zoetis says the new product is designed to stimulate both cell-mediated and antibody-based immunity, providing a broad immune response that mimics a natural infection.
The company says CircoMax Myco has demonstrated robust performance in field conditions, delivering improvements in average daily gain (ADG) and close-out weights versus negative controls, helping producers get more kilograms of pork to market.
CircoMax Myco comes in a ready to use single-dose combination with a duration of immunity (DOI) of 23 weeks against both PCV2 and M. hyopneumoniae.
Alvaro Aldaz, Director, Global Commercial Development, Swine, Zoetis, said: “The swine industry needs to adapt to evolving challenges and our research has consistently demonstrated that with its unique technology CircoMax Myco offers robust protection against PCV2 and M. hyopneumoniae.
"It also shows that this new product offers the best chance at protection against continuously evolving PCV2 genotypes – providing a broader umbrella for pig health and productivity.
"Analysis of new European PCV2 strains isolated in multiple countries confirm that CircoMax Myco offers broader coverage than competitor vaccines based on PCV2a only.”
Anyone unable to attend the latest in the increasingly popular BVA Animal Welfare Foundation discussion forums, held in May, can now catch up on the presentations on VETS.TV - the new web TV service currently being piloted by BVA - which can be accessed at www.vets.tv.
All the presentations, including ‘Put your money where your mouth is - can people afford animal welfare in food production', ‘Designer animals or breeding for welfare' and ‘Electric aid or shock collar' as well as the Norman Hayward Fund sponsored session - which included presentations on both the British Equine Veterinary Association (BEVA) and Edinburgh University laminitis studies and the casualty slaughter of sheep - along with the Chair of the BVA:AWF Trustees, Carl Padgett's summary of the day, are now available online to view at your convenience.
Also new on VETS.TV is an interview with Young Vet Network (YVN) senior graduate BVA Council representative, Louisa Rance who talks about the work of the YVN and how it is helping newly qualified vets with the challenges faced after leaving vet school and a series of videos, courtesy of Farmers Weekly, on Bluetongue - what it is, how it is transmitted, the symptoms and vaccination advice.
The Veterinary Marketing Association has 10 tickets available for its annual debate being held at the House of Lords on Tuesday October 12th, this year entitled: Internet Pharmacies - Opportunity or Threat?
The debate will be chaired by Professor Sandy Trees, and the panel will comprise:
The debate kicks off at 10:30am, and is followed by lunch at 12:30pm on the famous terrace, overlooking the Thames.
VetSurgeon members may buy tickets at the lower VMA member price of £120 + VAT, which includes the champagne reception and three course lunch with wine.
Click here for more information.
The new policy has been published ahead of an upcoming review of England’s Welfare of Animals at the Time of Killing regulations (WATOK) by the Department for Environment, Food and Rural Affairs (DEFRA).
Recommendations in the policy address all areas of the slaughter process, including:
The policy also covers a wider range of species and focuses on some of those species-specific needs.
For the first time its recommendations include fish. In order to improve the welfare of farmed finfish, BVA says that UK Governments should include the effective stunning of finfish as well as general welfare protections in WATOK regulations. It also calls for more research into developing effective and humane methods of stunning for decapods (shrimp, lobsters and crabs) and cephalopods (squid and octopus) as well as wild caught fish.
BVA Senior Vice President, Simon Doherty said: "With millions of animals slaughtered each year to provide us with the food we eat, we have a responsibility to provide them with a life worth living and a humane death. Our updated position aims to do just that by building on existing legislation and guiding the industry in a direction that better protects the welfare of animals destined for the food chain.
"Slaughter processes should be designed to minimise avoidable pain, distress, fear, and suffering and this document looks at all of the ways that we as vets can work with industry bodies and farm colleagues to improve the legislation already in place.”
A snapshot survey carried out in 2018 by the Food Standards Agency (FSA) for the period of one week revealed that nearly 20 million animals (excluding fish) were slaughtered across 248 operating plants in England and Wales during that time.
In order to effect change for such a high quantity of animals, BVA’s new position sets out recommendations for a range of stakeholders, government, industry, researchers and the veterinary profession, at each stage of the slaughter process. Improvements to the way that stunning data is captured and reported on is also on the list of asks, as well as improving regulation of non-stun slaughter and working collaboratively with Islamic scholars and Halal certification bodies to promote the acceptability of recoverable stunning.
Simon added: "From making sure that stunning methods are as effective as possible, to looking at the specific needs of each species, revalidation of training for operators, and championing the role of the Official Veterinarian, there is a lot of work to be done but we look forward to progressing these recommendations and working to improve the welfare of farmed animals across the UK."
The randomised controlled trial1 was conducted in 11 flocks with 6840 lambs during last year's lambing season (2023-2024), making it the largest ever navel protection study in the UK.
For the trial, odd numbered lambs were treated with strong iodine and even numbered lambs were treated with NoBACZ Navel.
Current practices on the farm were observed, so if the farmer normally dipped the lambs’ umbilicus they dipped with iodine or NoBACZ Navel and if they normally sprayed the umbilicus then they sprayed with iodine or NoBACZ Navel.
Survival and weights were recorded.
The study concluded that NoBACZ Navel demonstrated superior protection compared to iodine, with a 21% reduction in mortality (p=0.005).
On top of that, lambs that had NoBACZ Navel applied to the umbilicus and tagging sites were on average 230g heavier than those in the iodine group at eight weeks.
Fiona said: "Until now, best practice to manage navel ill has been to apply strong iodine to the umbilicus and ear-tagging sites by dipping or spraying to desiccate the umbilicus and disinfect the surface.
"Prophylactic antibiotic use also still occurs on as many as 19% of farms2, which is not best practice or good antimicrobial stewardship.
“NoBACZ Navel provides greater desiccation of the umbilicus than iodine and forms a non-colonisable waterproof barrier which protects lambs from the environment.
“The economic and welfare benefits to farmers are clear, with 17 more lambs alive per 1,000 born and an average of 230g extra bodyweight per lamb at eight weeks, which more than justifies the 16p per dose investment in NoBACZ Navel.
"During the trial I also received fantastic feedback from farmers on its ease of use and long-lasting protection to these vulnerable sites.”
www.nobacz.com
References
CEVA Animal Health has launched the anti-inflammatory Meloxidyl for cattle and pigs.
Meloxidyl is meloxicam-based solution for the management of respiratory disease, mastitis and diarrhoea in cattle and non-infectious locomotor disorders and puerperal septicaemia and toxaemia in pigs. It is given via a single injection, when used in combination with suitable anti-infectives.
According to the company, Meloxidyl's one shot protocol means it is quick and economical to use; it allows control of inflammation and endotoxins and reduces somatic cell count, recovery time and risk of culling after clinical mastitis; it reduces the economical impact of respiratory signs in comparison with flunixin-based products and reduces the major clinical signs caused by toxins in cases of neonatal diarrhoea.
Meloxidyl can be used in combination with the company's range of anti-infectives, which includes Marbokem, Cevaxel and Florkem.
For further product information contact CEVA Animal Health Ltd, 90 The Broadway, Chesham, Bucks, HP5 1EG, telephone 01494 781510 or visit the website at http://www.ceva.uk.com/
A new infographic and educational webinar are now available to share on social media, to increase farmer awareness and provide best practice guidance.
The infographic and webinar explain how vaccination is considered best practice for control of the disease, giving better disease control whilst ensuring responsible use of antibiotics.
Independent sheep veterinary consultant Dr Fiona Lovatt, who leads the cross-industry Sheep Antibiotic Guardian Group, said: "Despite EAE being responsible for over 35% of all abortion diagnoses, only one million of the 3.5 million replacement ewes in the national flock each year are vaccinated against EAE. Any sheep farmer that either buys in ewes for replacements or has close neighbours that also lamb sheep, risks bringing enzootic abortion into their flock.
"Once the disease infects an unvaccinated flock, some ewes are ‘programmed’ to abort at their next lambing, leaving no choice but to put remedial measures in place – usually including both vaccination and antibiotic treatment.
"This means EAE is a disease that, once in a flock, carries high costs both financially and emotionally in terms of lamb losses and farmer stress. Hence it is important that flocks receive appropriate vaccination at least four weeks before ewes go to the ram and avoid the inappropriate use of antibiotics closer to lambing."
Fiona points out that a single dose of EAE vaccine costs about £2.40 and is an investment that effectively lasts the ewe for her lifetime in the flock, protecting against losses. In contrast, abortion or stillbirth – which accounts for around a quarter of all lamb losses each year – costs over £25 for every single lost lamb.
Fiona added: "Every injection of antibiotics also costs an additional £1. But is just a ‘sticking plaster’ with short-lasting effectiveness in terms of disease control but long-lasting damage in terms of mounting resistance."
Ceva says it will continue to work closely with veterinary practices to secure stock of Cevac Chlamydia vaccine to ensure farmers can purchase and use the vaccine at the right time. Ceva also provides subsidised blood sampling for diagnostic purposes.
For further information, call Ceva Animal Health on 01494 781510 or email cevauk@ceva.com.
Photo: Mike Benjamin
MSD Animal Health has announced a new claim for Bovilis BVD and Bovilis IBR Marker Live vaccines which means they can be mixed and administered in a single syringe.
MSD says the new mixing claim will offer significant advantages in herd health planning when controlling two of the more important infectious diseases in cattle.
Bovine Viral Diarrhoea (BVD) and Infectious Bovine Rhinotracheitis (IBR) remain major threats to cattle health and productivity. Vaccinations are commonly given at housing and/or turnout, which are both busy times for veterinary surgeons and on the farm in the herd health planning calendar.
The mixed vaccines are suitable only for booster vaccinations of animals from 15 months of age previously vaccinated separately with Bovilis IBR Marker Live and Bovilis BVD. The mixed vaccine needs to be used within three hours.
MSD says the mixing procedure is clear and easy, but there is an instructional video here: http://www.msd-animal-health.co.uk/Mixing_bovilis_BVD_Bovilis_IBR-Marker_Live.aspx
Tom graduated from the Royal Veterinary College (RVC) in 2017 and joined Synergy Farm Health full-time in 2018, after completing his postgraduate diploma (PGDipVCP) with the RVC.
Nominated by his practice, Tom is described as a fine example of a dedicated caring professional who is passionate about sustainability, has a keen sense of his clients’ needs, and has developed strong working relationships with the farms under his care.
The judging panel found that Tom uses data effectively in herd health planning to highlight areas of improvement, working in partnership with his clients to promote disease prevention and profitability.
Tom’s clients spoke of his knowledge and caring attitude and how much he is valued as part of their team.
Tom said: “It was a privilege to be a part of the awards and to see farmers and businesses acknowledged - farmers don’t always get the recognition they deserve and seeing British dairying showcased was amazing.
"I hope winning is reward for the time and effort colleagues at Synergy put into young vets too, and that I can put it to good use supporting clients and working with other organisations within the dairy industry.
"My aim as a vet has been simply to support clients the best I could, both clinically and emotionally, so to have won made it a fantastic night and one I won’t be forgetting!”
The runner up as Charlie Mays of LLM Vets, who the judging panel praised for making effective changes on farm towards preventive healthcare and using data to assist with health and profitability.
Charlie also lobbies government to support the interests of the farmer and the industry.
Sabrina Jordan from Virbac said: ‘Virbac has been supporting dairy vets with products and services for over 50 years and recognise the commitment of young dairy vets to the profession.
"The standard of nominations into this category was outstanding, and our winner and highly commended nominees are a true credit to the veterinary profession, both are shining lights of the future’.
CEVA Animal Health has now introduced Colibird, the UK's first colistin-based soluble antimicrobial approved for poultry.
According to the company, colistin is an important active in the UK's antimicrobial armoury, with a potent bactericidal action against Gram-negative bacteria, including enterobacteria and more particularly E. coli. Colibird is only one of a handful of products approved for layers that has a zero egg withhold. It also has almost zero levels of resistance, even with bugs variously resistant to other antimicrobials and is easily and efficiently administered in drinking water via header tanks or dosing pumps.
For further information please contact the large animal sales team or CEVA Animal Health Ltd, 90 The Broadway, Chesham, Bucks, HP5 1EG.
The Farm Animal Welfare Council (FAWC) has launched its "Report on the implications of castration and tail docking for the welfare of lambs".
The report considers the implications of castration and tail docking for the welfare of lambs and reiterates FAWC's earlier view that castration and tail docking of lambs are mutilations which should not be undertaken without strong justification.
Professor Wathes, Chairman of FAWC, said: "FAWC believes that scientifically based advice can now be given that will minimise the suffering arising from castration and tail docking."
He continued "If castration is warranted, some methods cause more suffering than others and pain relief should be given once practical methods of delivering local anaesthetics and analgesics have been developed."
The full report is available for download at: http://www.fawc.org.uk/
The first, 'Factors that determine the success of a mastitis treatment' is tomorrow, Thursday 30th April, at 7:30pm. It will be presented by veterinary surgeon and researcher, Sofie Piepers.
The second webinar is titled 'Communication skills for effecting behaviour change with a focus on mastitis treatments'. Presented by Owen Atkinson, a vet with experience of the dairy industry around the world, the webinar will start at 7:30pm on Tuesday 5th May.
There will be opportunities to ask questions of both speakers at the end of each session.
For more information, visit: https://www.boehringer-academy.co.uk
The vaccine has been developed from Suvaxyn Circo+MH RTU, and also contains MetaStim as adjuvant 1.
MetaStim is an emulsion containing a metabolisable (non-mineral) oil and is used in vaccines to help elicit both humoral and a cell-mediated immune responses. Zoetis says it is thought to preserve the vaccine components so the antigens are released slowly as compared to other types of adjuvants2.
Alvaro Aldaz, Director Commercial Development and Innovation, Swine, Zoetis, said: "The safety and efficacy of MetaStim has been well documented given its use in several swine, cattle and equine vaccines for the past several years.
"In fact, the MetaStim adjuvant is currently used in our bivalent vaccine – Suvaxyn Circo+MH RTU. Suvaxyn Circo is the monovalent PCV2 fraction of the parent vaccine and it delivers a similar performance profile for PCV2 protection."
More than 250 million pigs are vaccinated against Circovirus every year in Europe.
Professor Hans Nauwynck, Director of the Laboratory of Virology at Ghent University said: "Vaccination of piglets against Circovirus has become a standard in pig farms across Europe.
"The goal is achieving strong immunity, both cell mediated and antibodies, against a virus that is always in the farm.
"Veterinarians should consider several factors when deciding the best timing for vaccination, being especially important the levels of maternal immunity in the pigs to be vaccinated, the presence of co-infections like PRRSV and the expected infection pattern in the farm."
Suvaxyn Circo is a new tool for veterinarians and producers who prefer monovalent vaccines. In situations where early vaccination of piglets against M.hyo is preferred, for example using Suvaxyn MH-One which is licensed for administration from one week of age, there will be a need to give a separate monovalent vaccine to cover PCV2. In such cases, Suvaxyn Circo from three weeks of age can be considered as an option.
Suvaxyn Circo is available in 50- and 125-dose vials.
For more information, contact your Zoetis representative.
Bayer Animal Health has announced the launch of, Dinalgen (ketoprofen), an NSAID injection approved for use in cattle, pigs and horses.
Dinalgen is available as a 150mg/ml Solution for Injection, and Bayer says the more concentrated format allows the product to provide the smallest dose, fast relief NSAID currently available for cattle in the UK.
In cattle, Dinalgen is licensed for the reduction of inflammation and pain associated with lameness, post-partum, and musculoskeletal disorders; the reduction of fever associated with bovine respiratory disease; and the reduction of inflammation, fever and pain in acute clinical mastitis in combination with antimicrobial therapy where appropriate. The withdrawal period for milk is zero hours and for meat two days.
In pigs, Dinalgen is licensed for the reduction of pyrexia in cases of respiratory disease and postpartum dysgalactia syndrome in sows, in combination with antimicrobial therapy.
In horses, Dinalgen is licensed for the reduction of inflammation and pain associated with osteoarticular and musculoskeletal disorders, including lameness, laminitis, osteoarthritis, synovitis, and tendinitis. It also aids the reduction of visceral pain associated with colic.
Sharon Cooksey, MRCVS, FAP group product manager at Bayer, said: “We are excited to have this new addition to our portfolio. It is a good fit with our existing products.
"A recent field study*, carried out by Nottingham university, has shown that NSAID (ketoprofen) treatment maximises the chance of recovery from lameness in dairy cattle. Lameness remains one of the “big three” issues in dairy practice so maybe it is time we moved on from hoof blocks and/ or trimming in isolation and onto a more multi-layer approach. We have some great support tools in the pipeline to help both vets and farmers recognise and manage animals at risk for lameness.”
For further product information visit www.noahcompendium.co.uk or contact your local Bayer territory manager.
SMITHS Detection, part of the global technology business Smiths Group, today announces it is to launch a portable detection system that will enable veterinarians to carry out on-site diagnosis of animal diseases such as foot-and-mouth and avian flu.
This new technology means vets will be able to diagnose diseases in livestock and birds in the field in less than 90 minutes rather than having to send samples for laboratory analysis.
The new system will be launched to vets at the World Association of Veterinary Laboratory Diagnosticians conference in Australia in November 2007 and is expected to be in production in mid 2008.
Veteran campaigner and RCVS Councillor Danny Chambers MRCVS (pictured right) has started a petition to George Eustice on change.org that: Future trade deals must not compromise animal welfare and public health.
The petition has gathered an impressive 21,984 signatures, of which Danny says that more than 500 are from veterinary surgeons.
Meanwhile VetPartners is calling on the retail and food service sector to give priority to British produce, even if future trade deals enable the import of foods produced to lower standards.
Ian Cure, farm director at VetPartners, is contacting the UK’s main retailers to discuss how they can support British farmers in the months and years to come. He has the backing of the clinical directors at each of the 28 farm or mixed practices within the group, which collectively look after the health and welfare of over 30% of the UK’s dairy population and 45% of the pig population.
“We are asking retailers to prioritise a range of Red Tractor certified produce at varying prices, while avoiding designating shelf space to imports of a lower quality. Likewise, the food service sector can choose to source from UK food supply chains.
“These sectors have a high level of influence, as consumers will pick from what is clearly available, which is why we see it as the best way to support our farmers.
“We are incredibly concerned about how the higher welfare and production standards in UK agriculture will be protected long term, given that MPs failed to enshrine that protection in law when voting against the recent amendment to the Agriculture Bill last month.
“Future trade deals to allow the import of cheap food from countries outside of the EU would be a step in the wrong direction, as our farmers will not be competing on an even playing field as they attempt to compete with countries with lower costs of production.”
However, Ian adds that this is not just a welfare issue: "If the UK livestock sector is forced to adopt practices that are frowned upon in Europe to compete, such as the American applications of hormone growth treatments and chlorinated chicken, we would be severely risking our local, lucrative European export market.
“While trade with countries such as the USA and Australia may have benefits from an economical perspective, the carbon emissions associated with longer distance transport of food is a real concern.
“We see it as imperative that higher welfare standards are maintained, while reducing the carbon footprint of our food supply – it's the right, sustainable thing to do. As MPs have let down the sector, we are now calling on retailers and the food service industry to back UK farming."
Veterinary practices are being encouraged to enter the annual Veterinary Marketing Association's (VMA) awards, which now include a practice-only category.
The annual VMA awards are intended to recognise excellence in all aspects of veterinary and animal health marketing. The Practice Marketing Award, sponsored by Pfizer, is awarded to the companion or production animal practice that demonstrates the most initiative and innovation in the marketing of its products and/or services to end users. This can involve the use of any form of activity, including advertising, websites, direct mail and media relations.
Last year's winner of this award was Kessock Equine Vets from Aberdeen, who travelled down to London to receive their award at a presentation lunch. The 2009 awards presentation ceremony takes place on Friday, 19th March at the Old Brewery in Chiswell Street, London. The meeting also presents a very good opportunity for vets to meet representatives from all the major animal health companies.
Tickets for the event cost £115+VAT for VMA/VMPA members (£150+VAT for non-members). The price includes a three-course meal (prepared by a two-star Michelin chef) with wine, a champagne reception and entertainment by a top comedian.
Further information on the awards is available on the Veterinary Marketing Association's website - http://www.vma.org.uk/. Closing date for entries is 5th February 2010.
BVA President Harvey Locke used his annual London dinner speech last night to urge the Government to take action on veterinary student fees and the welfare of dogs, and respond to the consultation on dangerous dogs.
Guests at the dinner included The Rt Hon Caroline Spelman MP, Secretary of State for Defra, parliamentarians, veterinary surgeons, and representatives from the agri-food industry, pet industry, welfare charities, research and veterinary education.
Mr Locke began by raising concerns over cuts to animal health and welfare and disease surveillance budgets: "In the Comprehensive Spending Review Defra took one of the biggest hits. The profession remains deeply concerned that cuts in research and development and disease surveillance could have catastrophic consequences. Right now the UK enjoys some of the highest animal health and welfare standards in the world and so it is in all of our interests to ensure the viability of the farming sector amidst massive competition from abroad, where those standards may not always be as high."
On veterinary student fees, Mr Locke outlined the 'double whammy' of a long course and compulsory Extra Mural Studies in the holidays: "Our role as the guardians of animal health and welfare faces an uncertain future following the announcement that the cap on tuition fees will be raised to between 6 and 9 thousand pounds a year. We fear this could have a huge impact on the decisions of A-level students, with fewer and fewer opting for an expensive veterinary science degree.
"Although the plans are not yet finalised we are bracing ourselves for veterinary degrees, which are costly to run, to be priced at the top of the scale, meaning veterinary students of the future will graduate with at least £45,000 of debt in tuition fees alone. Faced with these levels of debt, our concern is that those who do make it to graduation won't opt for the food animal practice and public health roles that attract smaller pay packages. We need to think carefully about how we can secure the future provision of large animal practitioners."
On companion animal issues Mr Locke asked Defra not to defer all decisions on dog welfare to the newly-formed Dog Advisory Council: "While the BVA fully supports the Advisory Council, we would urge the Government not to use it to delay decisions that might improve the health and welfare of dogs now. At a recent meeting of the Associate Parliamentary Group on Animal Welfare (APGAW) ...there was overwhelming support for provision for healthy breeding to be brought into Defra's welfare codes.
"We have long maintained that to ignore breeding in the dog welfare code is a serious oversight by Defra. In England we already have regulations that protect our farmed animals from breeding procedures that cause suffering or injury, but not for our pets. This contradictory approach makes little sense. Updating the welfare codes to include breeding would send a clear message that the Government is committed to improving the health and welfare of man's best friend."
On dangerous dogs Mr Locke renewed the BVA's call for the Government to respond to the Defra consultation, which found 77% in favour of scrapping breed-specific legislation: "Despite this overwhelming call from the public, the Government has kept its powder dry, repeatedly promising to announce its response soon.
"Secretary of State I would like to assure you that the BVA is prepared to work with all of the other organisations with an interest in dog welfare and public safety to find an effective solution. We all want to see people protected on private property; legislation that targets irresponsible owners and not just the way a dog looks; and tools that allow the police and other enforcement agencies to act swiftly to protect the public.
"And, crucially, we all want to work with you to achieve these aims."
Novartis Animal Health has announced the launch of Strenzen, an oral water medication for pigs, indicated for the treatment of gastrointestinal infections caused by Escherichia coli, Clostridium perfringens and Salmonella Typhimurium, and for respiratory tract infections caused by Actinobacillus pleuropneumoniae, Pasteurella multocida and Streptococcus suis.
Strenzen contains contains a combination of amoxicillin trihydrate (500 mg/g) and potassium clavulanate (125 mg/g) in ratio of 4:1. Novartis says it is ideally suited for the treatment of post-weaning infections in pigs.
According to the company, the combination of amoxicillin and clavulanic acid broadens the performance of amoxicillin1,2, especially against resistant strains of bacteria capable of producing ß-lactamase enzymes. Certain bacteria are able to produce ß-lactamase enzymes as a protection mechanism, making the amoxicillin molecule ineffective against them. The clavulanic acid in Strenzen binds to the molecules of the ß-lactamase enzyme, ensuring the amoxicillin remains unaffected and free to attack bacteria. Prof. Dominiek Maes, DVM, MSc, MS, PhD, Dipl. ECVPH, Dipl. ECPHM, from the Porcine Health Management Unit of the Ghent University, Belgium said: "Weaning is a stressful event for piglets and there are several opportunistic diseases that can impact them during this period. The challenge with E. coli and S. suis infections is that in many countries there are currently no commercial vaccines available with proper efficacy. I believe Strenzen can indeed be very helpful in managing those infections which are so prevalent after weaning."
Novartis says Strenzen is rapidly excreted, leading to a withdrawal period of one day, which in turn maximizes production flexibility for pig producers. In addition, the water-soluble formulation of Strenzen ensures that treated pigs get a therapeutic dose even when they stop eating, making it an ideal treatment for sick pigs with compromised appetites.
Recent field trials on infected farms in Spain and the Czech Republic demonstrated that Strenzen-treated pigs give better production performance, better economic returns and require less medical intervention3,4,5. The reduction of the overall amount of antibiotics needed to treat severe post-weaning infections not only saves producers the costs of the labour and the medication, but is also important in regard to the development of resistance in bacteria.
Dr. Ulrich Klein, Global Technical Services Manager, Novartis Animal Health said: "With the launch of Strenzen, Novartis Animal Health demonstrates its commitment to continually broadening our product portfolio to address the specific needs of farmers and food producers. Strenzen has the ideal spectrum for the treatment of post-weaning infections, delivering better productivity results than current therapies for those infections."
Vetoquinol UK has launched Marbocyl Solo – a one shot treatment for Bovine Respiratory Disease. Marbocyl Solo is a 100mg/ml solution of marbofloxacin given as one injection IM at 8mg/kg. It treats sick animals fast, killing bacteria in one go, therefore minimising lung damage and consequential morbidity. This fast action reduces the risk of the spread of infection. On top of that, Marbocyl Solo has a meat withdrawal of only 3 days (milk 3 days). “Marbocyl is a well proven antibacterial that is extensively used in cattle practice,” explains Alvin Cerely, Marbocyl’s product manager. “Marbocyl Solo is exceptionally well placed for applying ‘concentration killing’ or a‘strike action’ strategy as opposed to a ‘long action’ strategy used by other antibiotics. Marbocyl Solo is available as a separate presentation to Marbocyl 10% to avoid confusion, particularly with farmers, on different dosage regimes and withdrawal periods.”
Marbocyl Solo is available now and details have been mailed to all cattle vets in the UK and Ireland. Please contact your Vetoquinol representative or telephone 0800 169 8197 for more details.